Ge Guan

488 total citations
27 papers, 298 citations indexed

About

Ge Guan is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Ge Guan has authored 27 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Ge Guan's work include Ferroptosis and cancer prognosis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Ge Guan is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Ge Guan collaborates with scholars based in China, United States and Pakistan. Ge Guan's co-authors include Liqun Wu, Yueping Jiang, Junyu Huo, Xueguo Sun, Qian Dong, Qinghui Niu, Xue Jing, Huilan Su, Zhuoyu Li and Hongting Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Science Advances.

In The Last Decade

Ge Guan

26 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ge Guan China 10 81 68 59 57 51 27 298
Chengjian Ji China 13 173 2.1× 72 1.1× 98 1.7× 116 2.0× 48 0.9× 38 367
U Harréus Germany 9 118 1.5× 142 2.1× 50 0.8× 104 1.8× 80 1.6× 20 371
Yaxin Li China 9 66 0.8× 26 0.4× 33 0.6× 27 0.5× 30 0.6× 31 281
Xinxin Zhang China 12 134 1.7× 62 0.9× 179 3.0× 56 1.0× 33 0.6× 46 402
Mevlüde İnanç Türkiye 11 76 0.9× 168 2.5× 176 3.0× 56 1.0× 45 0.9× 31 353
Ken Pittman Australia 10 38 0.5× 139 2.0× 51 0.9× 26 0.5× 27 0.5× 23 292
Ewa Strauss Poland 13 102 1.3× 20 0.3× 144 2.4× 53 0.9× 112 2.2× 40 439
Zhongwei Zhou China 13 105 1.3× 60 0.9× 52 0.9× 49 0.9× 38 0.7× 31 442
Yibing Wang China 9 143 1.8× 65 1.0× 133 2.3× 78 1.4× 148 2.9× 29 434
C. Haberl Germany 11 54 0.7× 173 2.5× 158 2.7× 41 0.7× 83 1.6× 19 419

Countries citing papers authored by Ge Guan

Since Specialization
Citations

This map shows the geographic impact of Ge Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Guan more than expected).

Fields of papers citing papers by Ge Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Guan. The network helps show where Ge Guan may publish in the future.

Co-authorship network of co-authors of Ge Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Guan. A scholar is included among the top collaborators of Ge Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Guan. Ge Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Ge, et al.. (2025). NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis. Science Advances. 11(1). eadq5786–eadq5786. 6 indexed citations
2.
Kong, Yan, et al.. (2025). Effects of sleep deprivation on sports performance and perceived exertion in athletes and non-athletes: a systematic review and meta-analysis. Frontiers in Physiology. 16. 1544286–1544286. 3 indexed citations
3.
Zhao, Ziyin, Mingyang He, Ge Guan, et al.. (2024). Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis. Frontiers in Immunology. 15. 1474869–1474869. 2 indexed citations
4.
Jiang, Yueping, Ge Guan, Xueguo Sun, et al.. (2024). Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery. Annals of Surgical Oncology. 31(5). 2913–2924. 3 indexed citations
6.
Zhao, Ziyin, Tingting Guo, Mingyang He, et al.. (2023). STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
7.
Zhu, Qingwei, Wei Rao, Junyu Huo, et al.. (2023). Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center. BMC Gastroenterology. 23(1). 28–28. 2 indexed citations
8.
Ding, Xueli, et al.. (2023). Differential metabolites in cirrhotic patients with hepatitis B and muscle mass loss. Frontiers in Nutrition. 10. 1068779–1068779. 3 indexed citations
10.
Wang, Dong, Ning Fan, Yandong Sun, et al.. (2022). IV segment portal vein reconstruction in split-liver transplantation with extended right grafts. BMC Surgery. 22(1). 311–311. 1 indexed citations
11.
Liu, Chao, et al.. (2022). Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. BMC Cancer. 22(1). 496–496. 12 indexed citations
12.
Yang, Xin, Ge Guan, Junyu Huo, et al.. (2021). TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy. Pharmacogenomics and Personalized Medicine. Volume 14. 269–278. 11 indexed citations
13.
Guan, Ge, Junyu Huo, Xin Yang, et al.. (2021). The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine. Volume 14. 723–736. 4 indexed citations
14.
Huo, Junyu, et al.. (2021). A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 9. 761839–761839. 24 indexed citations
15.
Chen, Dexi, Bo Yao, Ge Guan, et al.. (2020). Effects of donor–recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients. International Immunopharmacology. 80. 106188–106188. 8 indexed citations
16.
Qi, Yu, Nana Zhang, Yan Jiang, et al.. (2018). RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma. SHILAP Revista de lepidopterología.
17.
Yu, Qianqian, Yan Jiang, Yuanyuan Lian, et al.. (2018). RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma. OncoTargets and Therapy. Volume 11. 7591–7600. 8 indexed citations
18.
Guan, Ge, Qianqian Yu, Huan Liu, et al.. (2018). Down-regulation of IFIT3 protects liver from ischemia-reperfusion injury. International Immunopharmacology. 60. 170–178. 8 indexed citations
19.
Lu, Hongting, et al.. (2014). Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α. International Journal of Molecular Medicine. 35(2). 349–357. 38 indexed citations
20.
Chen, Bo, et al.. (2009). An epidemiological survey on serum strontium levels in renal failure patients in China. Trace Elements and Electrolytes. 26(7). 122–130. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026